FORMULATION, DEVELOPMENT AND CHARACTERISATION OF NIMODIPINE LOADED SOLID LIPID NANOPARTICLES

REMYA P. N.; DAMODHARAN N.

doi:10.22159/ijap.2020v12i5.34342

Authors

REMYA P. N. Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamilnadu, India http://orcid.org/0000-0002-6490-8304
DAMODHARAN N. Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamilnadu, India

DOI:

https://doi.org/10.22159/ijap.2020v12i5.34342

Keywords:

Nimodipine, Solid lipid nanoparticles, Stearic acid, Palmitic acid, Tween-80

Abstract

Objective: The aim of the present study is to develop solid lipid nanoparticles (SLNs) of Nimodipine using hot homogenization followed by ultrasonication technique and to improve the dissolution characteristics of the drug.

Methods: The Nimodipine-loaded SLN was prepared using palmitic acid and stearic acid as a lipid matrix and Tween-80 as an emulsifier by a hot homogenization and ultra-sonication method. The physicochemical characteristics of SLN were investigated for entrapment efficiency, zeta potential, in vitro drug release, particle size analysis, Fourier transform infrared studies, scanning electron microscopy, and stability studies.

Results: The mean particle size, PDI, Zeta potential and entrapment efficiency of optimized Nimodipine SLN formulation of stearic acid was found to be 119.54 nm, 0.165,-17.60mV, 85% and for palmitic acid was found to be 132.54 nm, 0.155,-17.0mV, 81% respectively. In vitro drug release studies indicated that after an initial burst release, SLN could provide prolonged release of Nimodipine. The selected SLNs have shown good stability for a period of 180 d.

Conclusion: SLN formulations showed the best results in EE as well as in vitro drug release and therefore, these results indicate that SLN might be a promising delivery system to enhance the release of Nimodipine.

Downloads

Download data is not yet available.

References

Akter M, Banik S, Hossain MS. In vitro evaluation of oral extended-release drug delivery system for metoprolol succinate using kollidon SR. J Appl Pharm Sci 2012;25:188-92.

Muller RH, Maeder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of state of the art. Eur J Pharm Biopharm 2000;50:161-77.

Kaur IP, Singh H. Nanostructured drug delivery for better management of tuberculosis. J Controlled Release 2014;184:36-50.

Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water-soluble drug: zidovudine. Chem Pharm Bull 2010;58:650-5.

Svilenov H, Tzachev C. Solid lipid nanoparticles-a promising drug delivery system. Nanomedicine 2014;2:187-237.

Gastaldi L, Battaglia L, Peira E, Chirio D, Muntoni E, Solazzi I, et al. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. Eur J Pharm Biopharm 2014;87:433-44.

Ekambaram P, Sathali AA, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun 2012;2:80-102.

Yadav NE, Khatak SU, Sara US. Solid lipid nanoparticles-a review. Int J Appl Pharm 2013;5:8-18.

Basu T, Pal B, Singh S. Hollow chitosan nanocomposite as a drug carrier system for controlled delivery of nimodipine. Chem Phys Lett 2018;706:465-71.

Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 2007;8:12-7.

Sreelola VU, Sailaja AK, Pharmacy M. Preparation and characterisation of ibuprofen-loaded polymeric nanoparticles by a solvent evaporation technique. Int J Pharm Pharm Sci 2014;6:416-21.

Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781-5.

Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Delivery Rev 2012;64:83-101.

Dubes A, Parrot Lopez H, Abdelwahed W, Degobert G, Fessi H, Shahgaldian P, et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 2003;55:279-82.

Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of nimodipine nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227-43.

Senthil Kumar P, Arivuchelvan A, Jagadeeswaran A, Subramanian N. Formulation, optimization and evaluation of enrofloxacin solid lipid nanoparticles for sustained oral delivery. Asian J Pharm Clin Res 2015;8:231-6.

Poovi Ganesan, Damodharan Narayanasamy. Lipid nanoparticles: different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustainable Chem Pharm 2017;6:37-56.

Ekambaram P, Sathali AA. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharma 2011;3:216-20.

Remya PN, Damodharan. N formulation, development, and characterization of cilnidipine loaded solid lipid nanoparticles Asian J Pharm Clin Res 2018;11:120-5.

Marwah H, Garg T, Goyal AK, Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Delivery 2016;23:564-78.

Jensen LB, Magnussson E, Gunnarsson L, Vermehren C, Nielsen HM, Petersson K. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010;390:53-60.

Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 1999;16:205-13.

Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007;337:299-306.

Zimmermann E, Müller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 2000;196:211-3.

Havanoor SM. Isradipine loaded solid lipid nanoparticles for better treatment of hypertension–preparation, characterization and in vivo evaluation. Int J Biopharm 2014;5:218-24.